Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Neurana Pharmaceuticals logo — Pioneering new solutions for acute muscle spasms since 2013.

Neurana Pharmaceuticals

Pioneering new solutions for acute muscle spasms since 2013.

Founded 2013 Series A Total: $60.00M Biotechnology, Health Care +1

General Information

Company Name Neurana Pharmaceuticals
Founded Year 2013
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

Get notified when Neurana Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neurana Pharmaceuticals

Neurana Pharmaceuticals, a biotechnology company, has been revolutionizing the treatment of acute muscle spasms since its establishment in 2013. The California-based company has attracted significant attention, securing a noteworthy $60.00M Series A investment on 08 May 2018 from a group of prominent investors including H.I.G. BioHealth Partners, Longitude Capital, New Leaf Venture Partners, Sofinnova Investments, and MagnaSci Ventures. Specializing in the Biotechnology, Health Care, and Pharmaceutical sectors, Neurana Pharmaceuticals is committed to developing an innovative solution for acute muscle spasms, displaying considerable promise for the future of medical treatment.

Taxonomy: pharmaceuticals, acute muscle spasms, novel treatment, drug development, California, United States

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor Investor Investor
08 May 2018

Neurana Pharmaceuticals Alternatives & Competitors

Neurana Pharmaceuticals vs
UNICOBA_
UNICOBA_ Brazil

Acesse a company page oficial da UNICOBA em https://www.linkedin.com/company/96777. Acesse a comp...

333 employees
Manufacturing
Neurana Pharmaceuticals vs
Araneum
Araneum

Araneum Group srl is a consulting company. Araneum Group srl is a consulting company. Araneum Group...

16 employees
Information Technology, Internet
Neurana Pharmaceuticals vs
Cabinets City
Cabinets City

Company we will fill this later Company we will fill this later Company we will fill this later C...

6 employees
Design

FAQ About Neurana Pharmaceuticals

Pioneering new solutions for acute muscle spasms since 2013.
Neurana Pharmaceuticals was founded in 2013.
Neurana Pharmaceuticals operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Neurana Pharmaceuticals has completed 1 funding round, raising a total of $60.00M. The latest funding stage is Series A.
Top alternatives and competitors to Neurana Pharmaceuticals include UNICOBA_, Araneum, Cabinets City, Commonwealth Land Title Insurance Company ®, KDDB General Trading & Contracting Co. W.L.L. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurana Pharmaceuticals and UNICOBA_ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neurana Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes